Upadacitinib

Red

Brand Name(s):

Indication:Severe Rheumatoid Arthritis in Adults

Rationale:1,2

Considered:Jan-21

Review Date:Jan-26

Comments:
Upadacitinib is recommended for rheumatoid arthritis in adults after an inadequate response to a combination of conventional DMARDs, or 1 biological DMARD where rituximab is inappropriate, or where rituximab has also provided inadequate response.